Votruba Michal 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Votruba Michal
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-11+14,500→ 14,500 totalExercise: $37.86Exp: 2031-06-11→ Common Stock (14,500 underlying) - Other
Stock Option (Right to Buy)
2021-06-11−14,500→ 0 totalExercise: $37.86Exp: 2031-06-11→ Common Stock (14,500 underlying)
Footnotes (2)
- [F1]The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.
- [F2]The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date.